Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Oxaliplatin in Elderly Metastatic Colorectal Cancer
NCT00104689Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jun 2003
- Primary completion
- Mar 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in colorectal adenocarcinoma, sponsored by Unicancer. Started Jun 2003; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT00104689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104689.